McDonald's is investing $8.5 billion in a global restaurant refresh with new high-protein options like wraps and egg bites to serve evolving consumer preferences. Shake Shack and Chipotle have launched dedicated GLP-1-friendly menu sections featuring lettuce wraps, low-calorie bowls, and high-fiber options to address dietary shifts.
Fast-food chains revamp menus to cater to GLP-1 drug users
They want more protein, greater portion flexibility and food that leaves them feeling satisfied
Mark
Why does McDonald's care if GLP-1 users spend less? Aren't there plenty of other customers?
Mimi
There are, but the research shows an 8 percent drop in spending across the entire household—that's significant money walking out the door. And GLP-1 use is growing fast. The chains are trying to keep those customers engaged rather than lose them entirely.
Luke
But we should be careful here. The 8 percent figure is from one study. We don't know how many GLP-1 users there actually are, or whether that spending drop holds steady after six months, or whether it varies by region or income level.
Mark
So the chains might be overreacting?
Mimi
Or they might be reading the market correctly and getting ahead of a trend. McDonald's is spending $8.5 billion on a global refresh anyway—the GLP-1 angle is just one part of it.
Luke
Right. That's worth noting. This isn't a menu overhaul driven solely by GLP-1 users. It's a broader investment that happens to include options for them.
Mark
What do the actual GLP-1 users think of these menu changes?
Mimi
That's not in the reporting. We have what the chains are saying and what the research shows about spending, but not what customers themselves think about lettuce wraps instead of buns.
Luke
Exactly. We know the chains are making changes and why they think it matters. We don't know if it's working or if users actually want these options.
El Pulso
- McDonald's investing $8.5 billion in global restaurant refresh with high-protein options
- Shake Shack launched 'Good Fit Menu' in December with GLP-1-friendly choices
- Households with GLP-1 users cut restaurant spending by 8% in first six months
- Chipotle created dedicated website section for GLP-1 journey options
McDonald's is investing $8.5 billion in a global restaurant refresh with new high-protein options like wraps and egg bites to serve evolving consumer preferences. Shake Shack and Chipotle have launched dedicated GLP-1-friendly menu sections featuring lettuce wraps, low-calorie bowls, and high-fiber options to address dietary shifts.
Major fast-food chains including McDonald's, Chipotle, and Shake Shack are redesigning menus with high-protein and low-calorie options to retain customers using GLP-1 weight-loss drugs, which reduce appetite and change eating habits.
McDonald's, Chipotle, and Shake Shack are redesigning what they serve, and the reason is simple: millions of Americans taking weight-loss drugs are eating differently, and the chains want to keep them as customers.
The shift is most visible at McDonald's, which announced this week that it will roll out high-protein options including wraps and egg bites as part of an $8.5 billion global restaurant renovation. The company's leadership is explicit about the calculation. Chris Kempczinski, McDonald's chief executive, said in a recent interview that people on GLP-1 drugs—medications like Ozempic and Wegovy that suppress appetite—still want to eat at McDonald's. The company's job, he explained, is to make sure the menu reflects what those customers will be looking for. Skye Anderson, who leads McDonald's operations in the United States, put it more directly during a call with Wall Street analysts: the chain doesn't need to recruit new customers. Instead, it needs to give existing ones reasons to stay as their eating habits shift. Those customers want more protein, more flexibility in portion sizes, and food that satisfies without overwhelming them.
Other chains have moved faster. Shake Shack introduced its "Good Fit Menu" in December, featuring gluten-free and vegetarian options alongside choices explicitly marketed for people on GLP-1 drugs. Most of the burgers on that menu come wrapped in lettuce rather than served on buns. Chipotle has created a dedicated section of its website highlighting options for people on what the company calls their "GLP-1 journey"—bowls built with chicken and lettuce for lower calories, or chicken with rice for higher fiber.
The urgency behind these menu changes is rooted in hard data. Research published in the Journal of Marketing Research found that households with at least one person taking a GLP-1 drug cut their spending at fast-food restaurants, coffee shops, and other dining establishments by 8 percent within the first six months of starting the medication. That's a real loss of revenue, and it explains why chains are competing not to win new customers but to hold onto the ones they have as those customers' appetites and preferences change.
David Portalatin, a senior vice president at the market research firm Circana, told CBS News that having menu items tailored to this audience matters. He expects restaurants will continue diversifying their offerings, building out options that speak to different dietary needs and preferences. The fast-food industry is essentially acknowledging that the drugs have reshaped the market—not by shrinking it, but by changing what people want when they walk through the door.
Citas Notables
When people do go on GLP-1s, they still crave our food. We're going to evolve our menu to make sure it reflects where we think that consumer is going to be looking for in the future.— Chris Kempczinski, McDonald's CEO
We don't need to win a new base of customers into McDonald's. Instead, we need to keep giving them more reasons to make McDonald's their first choice as their eating habits evolve.— Skye Anderson, McDonald's USA president
Quieres la nota completa?
Lee el original en CBS News ↗